Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 64 Carcinoma, Hepatocellular 26 Prostatic Neoplasms 22 Neoplasm Metastasis 19 Neoplasms 18 Carcinoma, Non-Small-Cell Lung 16 Kidney Neoplasms 14 Osteosarcoma 9 Neuroendocrine Tumors 9 Colorectal Neoplasms 9 Carcinoma, Transitional Cell 9 Sarcoma 8 Carcinoma, Medullary 8 Urinary Bladder Neoplasms 7 Sarcoma, Ewing 7 Melanoma 7 Breast Neoplasms 7 Brain Neoplasms 7 Thyroid Neoplasms 6 Ovarian Neoplasms 6 Clear-cell metastatic renal cell carcinoma 6 Recurrence 5 Pancreatic Neoplasms 5 Lung Neoplasms 5 Carcinoma 5 Urethral Neoplasms 4 Triple Negative Breast Neoplasms 4 Multiple Myeloma 4 Thyroid Cancer, Papillary 3 Small Cell Lung Carcinoma 3

Interventions

Geriatric Assessment 10 epigallocatechin gallate 2 Preoperative Exercise 2 Nutritional Support 2 Nutrition Assessment 2 Exercise 2 Ascorbic Acid 2 peflavit 1 microcrystalline cellulose 1 fisetin 1 diacetamate 1 cabozantinib 1 Tretinoin 1 Therapeutics 1 Temozolomide 1 Standard of Care 1 Restraint, Physical 1 Resistance Training 1 Quercetin 1 Qigong 1 Psychosocial Intervention 1 Protons 1 Photons 1 Methods 1 Immunonutrition Diet 1 Flavonoids 1 Enhanced Recovery After Surgery 1 Dasatinib 1 Control Groups 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Frailty × cabozantinib × Clear all

NCT04134390 2024-01-09

CABOMAYOR

Spanish Oncology Genito-Urinary Group

Phase 2 Completed

Frailty, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡